Thread
:
ACH-4471 in trials for PNH treatment
View Single Post
#
1
Thu Mar 29, 2018, 01:23 PM
Marrowforums
Marrowforums.org
Join Date: Jul 2006
Posts: 919
ACH-4471 in trials for PNH treatment
Achillion Pharmaceuticals
is sponsoring a tiny
Phase II trial
of
ACH-4471
, a new drug for the treatment of PNH.
ACH-4471
inhibits a specific molecule
that is part of the complement process, and may reduce hemolysis.
ACH-4471 was
recently approved in Europe
for treatment of C3 glomerulopathy.
Marrowforums
View Public Profile
Visit Marrowforums's homepage!
Find all posts by Marrowforums